Evidence map›Paper›PMID 38433209›Full record

ArticleStem cell research & therapy2024

Induced pluripotent stem cell derived pericytes respond to mediators of proliferation and contractility.

Natalie E King, Jo-Maree Courtney, Lachlan S Brown, Alastair J Fortune, Nicholas B Blackburn, Jessica L Fletcher, Jake M Cashion, Jana Talbot, Alice Pébay, Alex W Hewitt and 4 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Generation of Donor-Specific iPSC for Modelling Lysosomal Storage Disorders.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Natalie E KingTasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Level 4, Medical Sciences Precinct, 17 Liverpool St, Hobart, TAS, 7000, Australia.
Jo-Maree CourtneyTasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Level 4, Medical Sciences Precinct, 17 Liverpool St, Hobart, TAS, 7000, Australia.
Lachlan S BrownTasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Level 4, Medical Sciences Precinct, 17 Liverpool St, Hobart, TAS, 7000, Australia.
Alastair J FortuneMenzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
Nicholas B BlackburnMenzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
Jessica L FletcherMenzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
Jake M CashionTasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Level 4, Medical Sciences Precinct, 17 Liverpool St, Hobart, TAS, 7000, Australia.
Jana TalbotWicking Dementia Education and Research Centre, College of Health and Medicine, University of Tasmania, Hobart, Australia.
Alice PébayDepartment of Anatomy and Physiology, The University of Melbourne, Melbourne, Australia.
Alex W HewittTasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Level 4, Medical Sciences Precinct, 17 Liverpool St, Hobart, TAS, 7000, Australia.
Gary P MorrisTasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Level 4, Medical Sciences Precinct, 17 Liverpool St, Hobart, TAS, 7000, Australia.
Kaylene M YoungMenzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
Anthony L CookWicking Dementia Education and Research Centre, College of Health and Medicine, University of Tasmania, Hobart, Australia.
Brad A SutherlandTasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Level 4, Medical Sciences Precinct, 17 Liverpool St, Hobart, TAS, 7000, Australia. brad.sutherland@utas.edu.au.ORCID 0000-0002-0791-0950
University of Tasmania · AUThe Royal Melbourne Hospital · AU

Funding

Medical Research Future Fund EPCD000008Multiple Sclerosis Australia 19-0696Multiple Sclerosis Australia 20-137Multiple Sclerosis Australia 21-3-023Multiple Sclerosis Australia 22-4-097National Health and Medical Research Council APP1137776National Health and Medical Research Council APP1163384
6 · The paper itself

Abstract

backgroundPericytes are multifunctional contractile cells that reside on capillaries. Pericytes are critical regulators of cerebral blood flow and blood-brain barrier function, and pericyte dysfunction may contribute to the pathophysiology of human neurological diseases including Alzheimers disease, multiple sclerosis, and stroke. Induced pluripotent stem cell (iPSC)-derived pericytes (iPericytes) are a promising tool for vascular research. However, it is unclear how iPericytes functionally compare to primary human brain vascular pericytes (HBVPs).

methodsWe differentiated iPSCs into iPericytes of either the mesoderm or neural crest lineage using established protocols. We compared iPericyte and HBVP morphologies, quantified gene expression by qPCR and bulk RNA sequencing, and visualised pericyte protein markers by immunocytochemistry. To determine whether the gene expression of neural crest iPericytes, mesoderm iPericytes or HBVPs correlated with their functional characteristics in vitro, we quantified EdU incorporation following exposure to the key pericyte mitogen, platelet derived growth factor (PDGF)-BB and, contraction and relaxation in response to the vasoconstrictor endothelin-1 or vasodilator adenosine, respectively.

resultsiPericytes were morphologically similar to HBVPs and expressed canonical pericyte markers. However, iPericytes had 1864 differentially expressed genes compared to HBVPs, while there were 797 genes differentially expressed between neural crest and mesoderm iPericytes. Consistent with the ability of HBVPs to respond to PDGF-BB signalling, PDGF-BB enhanced and a PDGF receptor-beta inhibitor impaired iPericyte proliferation. Administration of endothelin-1 led to iPericyte contraction and adenosine led to iPericyte relaxation, of a magnitude similar to the response evoked in HBVPs. We determined that neural crest iPericytes were less susceptible to PDGFR beta inhibition, but responded most robustly to vasoconstrictive mediators.

conclusionsiPericytes express pericyte-associated genes and proteins and, exhibit an appropriate physiological response upon exposure to a key endogenous mitogen or vasoactive mediators. Therefore, the generation of functional iPericytes would be suitable for use in future investigations exploring pericyte function or dysfunction in neurological diseases.

Indexed as

Induced Pluripotent Stem CellsPericytesAdenosineBecaplerminCell ProliferationEndothelin-1HumansAdenosineBecaplerminEndothelin-1AdenosineContractilityEndothelin-1Human brain vascular pericytes (HBVPs)Induced pluripotent stem cells (iPSCs)PericytesPlatelet-derived growth factor BB (PDGF-BB)Platelet-derived growth factor receptor β (PDGFRβ)Proliferation

Identifiers

PMID38433209
PMCPMC10910734
OpenAlexW4392363103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.